CZ334195A3 - Capsule made of soft gelatin and process for preparing thereof - Google Patents

Capsule made of soft gelatin and process for preparing thereof Download PDF

Info

Publication number
CZ334195A3
CZ334195A3 CZ953341A CZ334195A CZ334195A3 CZ 334195 A3 CZ334195 A3 CZ 334195A3 CZ 953341 A CZ953341 A CZ 953341A CZ 334195 A CZ334195 A CZ 334195A CZ 334195 A3 CZ334195 A3 CZ 334195A3
Authority
CZ
Czechia
Prior art keywords
pevný
capsule
particles
soft gelatin
oil
Prior art date
Application number
CZ953341A
Other languages
Czech (cs)
English (en)
Inventor
S Adusumilli Prasad
W James Kenneth
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of CZ334195A3 publication Critical patent/CZ334195A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Cosmetics (AREA)
CZ953341A 1993-06-18 1994-06-01 Capsule made of soft gelatin and process for preparing thereof CZ334195A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8085193A 1993-06-18 1993-06-18

Publications (1)

Publication Number Publication Date
CZ334195A3 true CZ334195A3 (en) 1996-03-13

Family

ID=22160037

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ953341A CZ334195A3 (en) 1993-06-18 1994-06-01 Capsule made of soft gelatin and process for preparing thereof

Country Status (20)

Country Link
US (1) US5595758A (cg-RX-API-DMAC10.html)
EP (1) EP0706381A4 (cg-RX-API-DMAC10.html)
JP (1) JPH08511559A (cg-RX-API-DMAC10.html)
KR (1) KR960703007A (cg-RX-API-DMAC10.html)
CN (1) CN1128947A (cg-RX-API-DMAC10.html)
AU (1) AU682880B2 (cg-RX-API-DMAC10.html)
BR (1) BR9407261A (cg-RX-API-DMAC10.html)
CA (1) CA2165415A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ334195A3 (cg-RX-API-DMAC10.html)
FI (1) FI956073L (cg-RX-API-DMAC10.html)
HU (1) HUT75670A (cg-RX-API-DMAC10.html)
MY (1) MY111000A (cg-RX-API-DMAC10.html)
NO (1) NO955149L (cg-RX-API-DMAC10.html)
NZ (1) NZ268480A (cg-RX-API-DMAC10.html)
PL (1) PL312260A1 (cg-RX-API-DMAC10.html)
RU (1) RU2134105C1 (cg-RX-API-DMAC10.html)
SK (1) SK158995A3 (cg-RX-API-DMAC10.html)
TW (1) TW292972B (cg-RX-API-DMAC10.html)
WO (1) WO1995000125A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA944325B (cg-RX-API-DMAC10.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0623018B1 (de) * 1992-01-17 1995-12-27 ALFATEC-PHARMA GmbH Verfahren zur herstellung von weichgelatinekapseln nach einem tropfverfahren
MY111346A (en) * 1993-07-09 1999-11-30 Smithkline Beecham Corp Soft-shelled gelatin encapsulated particles
DE19603402A1 (de) * 1995-02-24 1996-08-29 Basf Ag Weichgelatinekapseln
GB9605948D0 (en) * 1996-03-21 1996-05-22 Smithkline Beecham Plc Novel formulations
FR2747042B1 (fr) * 1996-04-05 1998-06-05 Besins Iscovesco Lab Medicament a base de progesterone et d'oestradiol
AUPP022297A0 (en) * 1997-11-06 1997-11-27 R.P. Scherer Holdings Pty Ltd Vitamin coating
WO2001019901A2 (en) * 1999-09-14 2001-03-22 Smithkline Beecham Corporation Process for making aqueous coated beadlets
US6365181B1 (en) 2000-04-20 2002-04-02 Gattefosse Corporation Thixatropic gelatin carrier composition
US6759395B2 (en) * 2000-12-18 2004-07-06 Orchid Chemicals & Pharmaceuticals, Ltd. Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
FR2832632B1 (fr) 2001-11-26 2004-04-23 Mane Fils V Capsule a solubilisation et liberation du contenu rapides
DE10392164T5 (de) * 2002-02-20 2004-10-28 Strides Arcolab Ltd. Oral verabreichbare pharmazeutische Formulierung
WO2003070154A2 (en) * 2002-02-20 2003-08-28 Strides Arcolab Limited Orally administrable pharmaceutical formulation comprising pseudoephedrine hydrochloride and process for preparing the same
US20030158264A1 (en) * 2002-02-20 2003-08-21 Ramachandran Radhakrishnan Orally administrable pharmaceutical formulation comprising ephedrine hydrochloride and process for preparing the same
US6926906B2 (en) * 2002-02-20 2005-08-09 M./S. Strides, Inc. Orally administrable pharmaceutical formulation
US20040033257A1 (en) * 2002-05-30 2004-02-19 Strides Inc. Pharmaceutical formulation in a drug delivery system and process for preparing the same
KR100780983B1 (ko) * 2003-07-31 2007-11-30 파마시아 앤드 업존 캄파니 엘엘씨 소염제의 분산성 제제
US20050053648A1 (en) * 2003-09-08 2005-03-10 Chalmers Anne Marie Medication delivery device
US9308164B2 (en) * 2004-06-30 2016-04-12 Sovereign Pharmaceuticals, Llc Hyoscyamine dosage form
GB0507167D0 (en) * 2005-04-08 2005-05-18 Glaxosmithkline Consumer Healt Composition
US20070253927A1 (en) * 2006-04-13 2007-11-01 Gwenaelle Jegou Cosmetic compositions comprising at least one dielectrophile monomer and at least one radical initiator
US8297959B2 (en) * 2006-05-03 2012-10-30 Terapia Celular, Ln, Inc. Systems for producing multilayered particles, fibers and sprays and methods for administering the same
AU2007323674B2 (en) * 2006-11-21 2013-05-23 Mcneil-Ppc, Inc. Modified release analgesic suspensions
US9833510B2 (en) * 2007-06-12 2017-12-05 Johnson & Johnson Consumer Inc. Modified release solid or semi-solid dosage forms
US20090196907A1 (en) * 2008-01-31 2009-08-06 Bunick Frank J Edible film-strips for immediate release of active ingredients
JP5622185B2 (ja) * 2008-02-25 2014-11-12 三生医薬株式会社 粉末高含有軟カプセル及びその製造方法
CA2706270C (en) * 2010-06-03 2020-01-07 Accucaps Industries Limited Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation
CA3065589C (en) * 2010-06-03 2022-04-26 Catalent Ontario Limited Multi phase soft gel capsules, apparatus and method thereof
US8287904B2 (en) * 2010-08-19 2012-10-16 Lionel Borkan Stable soft capsule dosage form for acetylsalicylic acid
EP3100721B1 (en) * 2014-01-31 2020-08-26 Fuji Capsule Co., Ltd. Capsule formulation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS603045B2 (ja) * 1976-04-19 1985-01-25 中外製薬株式会社 １α―ヒドロキシビタミンＤ類軟カプセルの製造方法
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
DD148185A1 (de) * 1979-05-21 1981-05-13 Claus Claussen Verfahren zur herstellung einer oral applizierbaren arzneiform
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
US4612187A (en) * 1983-04-26 1986-09-16 Nisshin Chemicals Co., Ltd. Oryzanol-containing soft capsule
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
AT382377B (de) * 1985-04-27 1987-02-25 Beecham Group Plc Verfahren zur herstellung von neuen 7-substituierten aminopyrazolo(4,3-b)pyridinen
US4760073A (en) * 1986-04-11 1988-07-26 Schering Corporation Aryl-substituted naphthyridine and pyridopyrazine derivatives, useful as anti-allergic agents
US5002777A (en) * 1986-06-24 1991-03-26 Norcliff Thayer Inc. Encapsulated antacid
US4656028A (en) * 1986-06-24 1987-04-07 Norcliff Thayer Inc. Encapsulated antacid
US4822611A (en) * 1986-12-09 1989-04-18 Immunotec, Inc. Oral hyposensitization in the treatment of allergies
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
FR2624012B1 (fr) * 1987-12-07 1991-05-31 Fdb Ste Civile Rech Nouvelles compositions pharmaceutiques a action hypnotique a base d'hydrate de chloral
US5175002A (en) * 1991-10-02 1992-12-29 Du Pont Merck Pharmaceutical Company Amantadine hydrochloride syspension with enhanced dissolution characteristics for use in soft gelatin capsules
JP3157233B2 (ja) * 1991-11-22 2001-04-16 エーザイ株式会社 水溶性薬物を含有した軟カプセル剤
MX9306393A (es) * 1992-10-16 1994-04-29 Glaxo Group Ltd Composiciones de ranitidina substancialmente libres de sabor amargo, proceso para su preparacion y composiciones farmaceuticas que las contienen.

Also Published As

Publication number Publication date
PL312260A1 (en) 1996-04-15
BR9407261A (pt) 1996-09-24
NO955149L (no) 1996-01-29
TW292972B (cg-RX-API-DMAC10.html) 1996-12-11
HUT75670A (en) 1997-05-28
JPH08511559A (ja) 1996-12-03
EP0706381A4 (en) 1997-02-26
NZ268480A (en) 1997-10-24
ZA944325B (en) 1995-02-10
AU7139594A (en) 1995-01-17
RU2134105C1 (ru) 1999-08-10
WO1995000125A1 (en) 1995-01-05
FI956073A7 (fi) 1996-02-16
FI956073L (fi) 1996-02-16
HU9503595D0 (en) 1996-02-28
SK158995A3 (en) 1997-02-05
US5595758A (en) 1997-01-21
MY111000A (en) 1999-07-31
AU682880B2 (en) 1997-10-23
FI956073A0 (fi) 1995-12-18
NO955149D0 (no) 1995-12-18
CN1128947A (zh) 1996-08-14
EP0706381A1 (en) 1996-04-17
CA2165415A1 (en) 1994-12-19
KR960703007A (ko) 1996-06-19

Similar Documents

Publication Publication Date Title
CZ334195A3 (en) Capsule made of soft gelatin and process for preparing thereof
Kimelberg Differential distribution of liposome-entrapped [3H] methotrexate and labelled lipids after intravenous injection in a primate
FI97686C (fi) Menetelmä helmien valmistamiseksi tarkoituksena tuottaa hallitusti vapauttavia tuotteita
CA2132451C (en) Process for the preparation of sustained release pellets
CA1297012C (en) Pharmaceutical compositions for inhalation
US20030104048A1 (en) Pharmaceutical dosage forms for highly hydrophilic materials
JP2000508309A (ja) エストラジオールおよびプロゲステロンをベースとした配伍剤
RU2006112589A (ru) Фармацевтические композиции для лечения преждевременной эякуляции при помощи легочной ингаляции
CN105377247B (zh) 用于治疗溃疡性结肠炎含磷脂酰胆碱的药物制剂
DE3603564A1 (de) Pharmazeutische praeparate mit analgetrischer wirksamkeit, sowie deren herstellung und verwendung
US6126967A (en) Extended release acetaminophen particles
Peatfield Drugs and the treatment of migraine
JP5944817B2 (ja) カプセル剤
JP2009517445A (ja) 活性成分の放出時間が長い組成物、その調製方法および利用方法
ITMI20010220A1 (it) Formulazioni multiparticolate per somministrazione orale di sali di litio idonee per una somministrazione al giorno
GB2276319A (en) Paracetamol compositions
JPS5921615A (ja) 鎮痛剤組成物
Jones et al. Kapanol™ capsules: pellet formulation provides alternative methods of administration of sustained-release morphine sulfate
CN109069439A (zh) 用于预处理癌症的组合物和方法
JPS5839619A (ja) 医薬組成物及びその製造方法
CN101708184A (zh) 铁脂质体的药物应用
RS59176B1 (sr) Direktni granulat sa aktivnim sredstvom za produženo oslobađanje
NZ195620A (en) Medicament containing aspirin and heptaminol
JPH03193733A (ja) テオフィリンの徐放性製剤
Dunnick et al. Studies of radiopharmaceutical-enclosing lipid-protein vesicles formed from native plasma components